BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 745013)

  • 1. Absence of "cheese effect" during deprenyl therapy: some recent studies.
    Sandler M; Glover V; Ashford A; Stern GM
    J Neural Transm; 1978; 43(3-4):209-15. PubMed ID: 745013
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The inhibition of tyramine oxidation and the tyramine hypertensive response ("cheese effect") may be independent phenomena.
    Sandler M; Glover V; Ashford A; Esmail A
    J Neural Transm; 1980; 48(4):241-7. PubMed ID: 6775051
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is the failure of (-)deprenyl, a selective monoamine oxidase B inhibitor, to alleviate depression related to freedom from the cheese effect?
    Mendis N; Pare CM; Sandler M; Glover V; Stern GM
    Psychopharmacology (Berl); 1981; 73(1):87-90. PubMed ID: 6785797
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tyramine pressor sensitivity changes during deprenyl treatment.
    Sunderland T; Mueller EA; Cohen RM; Jimerson DC; Pickar D; Murphy DL
    Psychopharmacology (Berl); 1985; 86(4):432-7. PubMed ID: 3929314
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Mechanism of inhibition by chlorgyline and deprenyl of tyramine deamination by mitochondrial monoamine oxidase of rat liver].
    Deverina IS
    Biokhimiia; 1980 Oct; 45(10):1897-908. PubMed ID: 6786369
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic applications of selective and non-selective inhibitors of monoamine oxidase A and B that do not cause significant tyramine potentiation.
    Youdim MB; Weinstock M
    Neurotoxicology; 2004 Jan; 25(1-2):243-50. PubMed ID: 14697899
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effect of solubilization by methylethylketone of rat liver mitochondrial monoamine oxidase on inhibition by clorgyline and deprenyl of the enzyme activity].
    Severina IS; Klimova GI; Nersisian AA
    Biokhimiia; 1981 Nov; 46(11):2043-55. PubMed ID: 6797482
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monoamine oxidase activity and monoamine metabolism in brains of parkinsonian patients treated with l-deprenyl.
    Riederer P; Youdim MB
    J Neurochem; 1986 May; 46(5):1359-65. PubMed ID: 2420928
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monoamine oxidase in bovine thyroid tissue.
    Masini-Repiso AM; Cabanillas AM; Andrada MC; Coleoni AH
    Horm Metab Res; 1986 Nov; 18(11):750-3. PubMed ID: 3098663
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of various monoamine oxidase (MAO) inhibitors on the response of blood pressure of rats and cats to tyramine.
    Abdo-Rubo A
    Acta Physiol Hung; 1990; 75(4):321-36. PubMed ID: 2127505
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monoamine oxidase inhibitors and their pharmacological significance.
    Sandler M
    Acta Neurol Scand Suppl; 1983; 95():37-41. PubMed ID: 6428147
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacology of MAO B inhibitors: mode of action of (-)deprenyl in Parkinson's disease.
    Youdim MB
    J Neural Transm Suppl; 1986; 22():91-105. PubMed ID: 3097263
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Platelet monoamine oxidase in Parkinson patients: effect of L-deprenyl therapy.
    Lee DH; Mendoza M; Dvorozniak MT; Chung E; van Woert MH; Yahr MD
    J Neural Transm Park Dis Dement Sect; 1989; 1(3):189-94. PubMed ID: 2505797
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monoamine oxidase inhibitors and the cheese effect.
    Anderson MC; Hasan F; McCrodden JM; Tipton KF
    Neurochem Res; 1993 Nov; 18(11):1145-9. PubMed ID: 8255365
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [History of deprenyl--the first selective inhibitor of monoamine oxidase type B].
    Knoll J
    Vopr Med Khim; 1997; 43(6):482-93. PubMed ID: 9503565
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tyramine-induced noradrenaline release from rat brain slices: prevention by (-)-deprenyl.
    Glover V; Pycock CJ; Sandler M
    Br J Pharmacol; 1983 Sep; 80(1):141-8. PubMed ID: 6418254
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effect of protein denaturing reactions on retardation of the activity of rat liver mitochondrial monoamine oxidase by clorgyline and deprenyl].
    Severina IS
    Biokhimiia; 1983 Sep; 48(9):1513-21. PubMed ID: 6414536
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of long-term treatment with selective monoamine oxidase A and B inhibitors on dopamine release from rat striatum in vivo.
    Lamensdorf I; Youdim MB; Finberg JP
    J Neurochem; 1996 Oct; 67(4):1532-9. PubMed ID: 8858937
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Possible mechanism of selective inhibition of rat liver mitochondrial monoamine oxidase by chlorgiline and deprenyl].
    Severina IS
    Biokhimiia; 1979 Feb; 44(2):195-207. PubMed ID: 435561
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential trace amine alterations in individuals receiving acetylenic inhibitors of MAO-A (clorgyline) or MAO-B (selegiline and pargyline).
    Murphy DL; Karoum F; Pickar D; Cohen RM; Lipper S; Mellow AM; Tariot PN; Sunderland T
    J Neural Transm Suppl; 1998; 52():39-48. PubMed ID: 9564606
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.